Day 2: Wednesday, February 17, 2027.
Continue the conversation with perspectives on innovations, CAMPs and the business of wound care.
Illustrative program — subject to change. Times and speaker assignments will be confirmed by the event team.
Day 2: Friday, May 15, 2026.
Main Auditorium
Session 1: Diagnostics and Innovations
-
Speaker: Jeffrey Niezgoda
Adequate tissue oxygenation is fundamental to wound healing, influencing cellular metabolism, angiogenesis, collagen synthesis, and host defense. This talk explores oxygenation as a key, quantifiable indicator of wound viability and healing potential. It will review the physiological role of oxygen in acute and chronic wounds, mechanisms underlying hypoxia-driven impaired healing, and the relationship between oxygenation, perfusion, and inflammation. Emerging tools for assessing tissue oxygenation—including transcutaneous oxygen measurements, near-infrared spectroscopy, and other optical technologies—will be discussed with an emphasis on clinical applicability.
-
Speaker: Dr. Jeffrey Niezgoda
-
Speaker: Dr. Marcus Gitterle
-
Speaker: TBC
-
Take time to enjoy refreshments, connect with fellow attendees, and explore the exhibition during this break
Session 2: Business in Wound Care
-
Speaker: Martha Kelso
This session reveals smart strategies to boost revenue, streamline operations, and keep your practice thriving, despite recent changes to reimbursement. Attendees will walk away with actionable insights to grow sustainably without compromising patient care.
-
Speaker: Dr. Thomas Serena
In this session, Dr. Serena explains the key findings of the CAMPs evidence consensus document published in IJTR.
-
Speaker: Moira Sykstus
Regulatory compliance has long been the foundation of defensible wound care—but today, it is no longer enough. In this session, we examine the escalating enforcement environment surrounding skin substitute therapies and the profound consequences for wound care practices nationwide. Drawing from real‑world audit activity, this presentation explores how retrospective enforcement, aggressive extrapolation, and payment recoupments are occurring even when providers meet coverage, documentation, and medical necessity standards. Attendees will gain insight into how audit actions are increasingly bypassing meaningful due process, leaving practices financially exposed long before appeals are resolved—and in some cases, forcing closures before adjudication ever occurs.
This program reframes the current audit landscape as not just a compliance challenge, but a practice survival issue, highlighting the disconnect between regulatory intent and operational reality. Participants will leave with a clearer understanding of emerging audit risks, why traditional compliance strategies may fail under current enforcement models, and what proactive steps leaders must consider for protecting clinical autonomy, financial viability, and patient access to advanced wound therapies. Ideal for: executives, medical directors, compliance leaders, wound care providers, and revenue cycle professionals navigating skin substitute utilization in today’s enforcement‑driven environment.
-
Speaker: To be announced soon!
This symposium will feature presentations sponsored by our industry partners. Specific topics and sponsors will be announced in due course
-
Take time to enjoy refreshments, connect with fellow attendees, and explore the exhibition during this break
-
Speaker: Kris Flinn
Explore the factors driving the Advanced Wound Care Market, including the latest market size and growth estimates.
-
Speaker: Dr. Justin Gooden
and Dr. William TettelbachThis session will look at the recently published NCD consensus and the future of coverage.
-
Speaker: Jennie Feight
Understanding the coding, coverage, and reimbursement mechanisms for wound care modalities, provides useful context for providers and administrators when navigating financial and clinical outcomes. This practical session will include current coding, billing, and payer requirements that impact wound care services, with emphasis on common challenges, documentation best practices, and strategies to support appropriate reimbursement.
-
Take time to enjoy refreshments, connect with fellow attendees, and explore the exhibition during this break
Session 3: CAMPs
-
Speaker: Dr. Michael Desvigne
Cellular, acellular, and matrix-like products (CAMPs) have rapidly expanded the therapeutic armamentarium of the modern plastic surgeon. These products promise improved wound healing, tissue regeneration, and aesthetic and reconstructive outcomes. However, alongside their growing popularity lies ongoing debate regarding their safety, efficacy, regulation, and appropriate clinical use. This talk examines CAMPs as both a potential friend and foe in plastic surgery.
-
Speaker: Dr. Abigail Chaffin
Through clinical examples and evidence-based discussion, this presentation will examine where CAMPs integrate into the reconstructive ladder, how they can shorten the reconstructive ladder and help avoid more invasive procedures, and when they meaningfully improve outcomes versus add cost or complexity. This session aims to help surgeons thoughtfully incorporate CAMPs into modern practice while preserving sound surgical principles and patient-centered care.
-
Panel: Dr. Michael Desvigne, Dr. Abigail Chaffin, Dr. Mark Suski, Dr Daniel Kapp
Moderator: Dr. Thomas Davenport
This panel discussion brings together leading plastic surgeons to address the fundamental questions surrounding CAMPs: Who should be using them, what products are appropriate for specific indications, whythey should be chosen over traditional reconstructive options, and when their use is truly justified.
-
